Shares of Avantor AVTR rose in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were up 52.63% over the past year to $0.29, which beat the estimate of $0.26.
Revenue of $1,791,000,000 up by 17.52% year over year, which beat the estimate of $1,690,000,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Avantor hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Feb 03, 2021
Time: 05:00 PM
ET Webcast URL: https://event.on24.com/wcc/r/2948500/8B4362B553C7B00357AF20EE10DA6765
Technicals
52-week high: $30.99
Company's 52-week low was at $6.66
Price action over last quarter: Up 27.34%
Company Overview
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
